A Deep Dive into Peripheral Artery Disease with Jennifer Jones-McMeans – Health Innovation Matters
Michael chats with Jennifer Jones-McMeans, Divisional Vice President of Global Clinical Affairs at Abbott’s cardiovascular business. Together, they discuss what peripheral artery disease (PAD) is, warning signs of PAD, how PAD affects patient life, how to prevent the disease, treatment options, and much more.
Learn more about PAD, symptoms, risks, and treatments at PAD-info.com.
About Our Guest
Jennifer Jones-McMeans is the Divisional Vice President of Global Clinical Affairs at Abbott’s cardiovascular business. Jennifer is invested in driving innovation and leveraging technology to create diversity in clinical trials and has become one of the leading experts in clinical trial design strategy.
Since joining Abbott, Jennifer has worked on gaining approval for numerous medical devices in the United States and globally. Jennifer has led many clinical trials, including those for resorbable technologies designed to treat cardiovascular disease and peripheral arterial disease. In 2021, Jennifer launched a new initiative designed to help create a more inclusive clinical trial ecosystem and clinical research infrastructure.
Health Innovation Matters 